Scott Vuocolo

7.8k total citations · 2 hit papers
37 papers, 3.8k citations indexed

About

Scott Vuocolo is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Scott Vuocolo has authored 37 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 17 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Scott Vuocolo's work include Cervical Cancer and HPV Research (24 papers), Hepatitis B Virus Studies (17 papers) and Genital Health and Disease (15 papers). Scott Vuocolo is often cited by papers focused on Cervical Cancer and HPV Research (24 papers), Hepatitis B Virus Studies (17 papers) and Genital Health and Disease (15 papers). Scott Vuocolo collaborates with scholars based in United States, Australia and Mexico. Scott Vuocolo's co-authors include Richard M. Haupt, Anna R. Giuliano, David Radley, Joel M. Palefsky, Edson Duarte Moreira, Daron Ferris, Heiko Jessen, Stephen E. Goldstone, Dalya Güriş and Janine T. Bryan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Scott Vuocolo

36 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

2011 821 citations Anna R. Giuliano, Joel M. Palefsky et al. New England Journal of Medicine profile →
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

2011 650 citations Joel M. Palefsky, Anna R. Giuliano et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Scott Vuocolo	3.1k	1.7k	472	468	405	37	3.8k
Karl Ulrich Petry	3.3k 1.1×	1.6k 1.0×	1.1k 2.2×	357 0.8×	692 1.7×	101	4.3k
Silvia de Sanjosé	4.0k 1.3×	2.1k 1.2×	1.2k 2.5×	310 0.7×	724 1.8×	96	5.1k
Heather Cubie	3.1k 1.0×	1.2k 0.7×	660 1.4×	250 0.5×	633 1.6×	104	3.6k
Ana Cecilia Rodríguez	2.5k 0.8×	1.0k 0.6×	380 0.8×	673 1.4×	355 0.9×	39	3.1k
Jeanne M. Pimenta	2.3k 0.7×	1.4k 0.9×	309 0.7×	162 0.3×	169 0.4×	55	2.9k
François Coutlée	2.6k 0.8×	1.6k 0.9×	535 1.1×	190 0.4×	340 0.8×	86	3.2k
Nubia Muñóz	4.5k 1.4×	2.9k 1.7×	788 1.7×	448 1.0×	555 1.4×	52	5.7k
Mark Schiffman	4.0k 1.3×	1.8k 1.1×	636 1.3×	674 1.4×	699 1.7×	60	4.6k
Eftyhia Vardas	1.5k 0.5×	630 0.4×	258 0.5×	440 0.9×	341 0.8×	52	2.4k
Margaret M. Madeleine	3.7k 1.2×	2.7k 1.6×	2.3k 4.8×	638 1.4×	574 1.4×	81	6.4k

Countries citing papers authored by Scott Vuocolo

Since Specialization

Citations

This map shows the geographic impact of Scott Vuocolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Vuocolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Vuocolo more than expected).

Fields of papers citing papers by Scott Vuocolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Vuocolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Vuocolo. The network helps show where Scott Vuocolo may publish in the future.

Co-authorship network of co-authors of Scott Vuocolo

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Vuocolo. A scholar is included among the top collaborators of Scott Vuocolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Vuocolo. Scott Vuocolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siegel, David S., Meletios Α. Dimopoulos, Sundar Jagannath, et al.. (2016). VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 16(6). 329–334.e1. 23 indexed citations

Moreira, Edson Duarte, Anna R. Giuliano, Joel M. Palefsky, et al.. (2014). Incidence, Clearance, and Disease Progression of Genital Human Papillomavirus Infection in Heterosexual Men. The Journal of Infectious Diseases. 210(2). 192–199. 37 indexed citations

Barnard, Richard J. O., John A. Howe, Robert A. Ogert, et al.. (2013). Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies. Virology. 444(1-2). 329–336. 54 indexed citations

Luna, Joaquín, et al.. (2013). Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil™ in Adult Women. PLoS ONE. 8(12). e83431–e83431. 72 indexed citations

Dimopoulos, Meletios Α., David S. Siegel, Sagar Lonial, et al.. (2013). Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study. The Lancet Oncology. 14(11). 1129–1140. 181 indexed citations

Goldstone, Stephen E., Heiko Jessen, Joel M. Palefsky, et al.. (2013). Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine. 31(37). 3849–3855. 38 indexed citations

Goldstone, Stephen E. & Scott Vuocolo. (2012). A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18. Expert Review of Vaccines. 11(4). 395–406. 10 indexed citations

Brown, Darron R., Suzanne M. Garland, Daron G. Ferris, et al.. (2011). The humoral response to Gardasil over four years as defined by Total IgG and competitive Luminex immunoassay. Human Vaccines. 7(2). 230–238. 90 indexed citations

Palefsky, Joel M., Anna R. Giuliano, Stephen E. Goldstone, et al.. (2011). HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia. New England Journal of Medicine. 365(17). 1576–1585. 650 indexed citations breakdown →

10.

Moreira, Edson Duarte, Joel M. Palefsky, Anna R. Giuliano, et al.. (2011). Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults. Human Vaccines. 7(7). 768–775. 27 indexed citations

11.

Vardas, Eftyhia, Anna R. Giuliano, Joel M. Palefsky, et al.. (2010). External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents. The Journal of Infectious Diseases. 203(1). 58–65. 86 indexed citations

12.

Palefsky, Joel M., Anna R. Giuliano, Edson Duarte Moreira, et al.. (2010). Prevalence of and Risk Factors for Human Papillomavirus (HPV) Infection Among HIV-Seronegative Men Who Have Sex With Men. The Journal of Infectious Diseases. 203(1). 66–74. 150 indexed citations

13.

Vesikari, Timo, Pierre Van Damme, David Radley, et al.. (2010). An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine Given Concomitantly With Diphtheria, Tetanus, Pertussis, and Poliomyelitis Vaccine in Healthy Adolescents 11 to 17 Years of Age. The Pediatric Infectious Disease Journal. 29(4). 314–318. 37 indexed citations

14.

Velicer, Christine, et al.. (2009). Prevalence and Incidence of HPV Genital Infection in Women. Sexually Transmitted Diseases. 36(11). 696–703. 44 indexed citations

15.

Muñóz, Nubia, Punee Pitisuttithum, Damrong Tresukosol, et al.. (2009). Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial. The Lancet. 373(9679). 1949–1957. 362 indexed citations

16.

Petrović, Jelena, A. Ngai, Susan K. Bradshaw, et al.. (2007). Efficacy and Safety of Caspofungin in Solid Organ Transplant Recipients. Transplantation Proceedings. 39(10). 3117–3120. 15 indexed citations

17.

Soprano, Kenneth J., Enkhtsetseg Purev, Scott Vuocolo, & Dianne Robert Soprano. (2006). Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid. Oncogene. 25(38). 5315–5325. 27 indexed citations

18.

Vuocolo, Scott, Dianne Robert Soprano, & Kenneth J. Soprano. (2004). p27/Kip1 mediates retinoic acid‐induced suppression of ovarian carcinoma cell growth. Journal of Cellular Physiology. 199(2). 237–243. 10 indexed citations

19.

Vuocolo, Scott, Enkhtsetseg Purev, Dongmei Zhang, et al.. (2003). Protein Phosphatase 2A Associates with Rb2/p130 and Mediates Retinoic Acid-induced Growth Suppression of Ovarian Carcinoma Cells. Journal of Biological Chemistry. 278(43). 41881–41889. 38 indexed citations

20.

Zhang, Dongmei, Scott Vuocolo, Valeria Masciullo, et al.. (2001). Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression. Oncogene. 20(55). 7935–7944. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact